medigraphic.com
SPANISH

Revista Cubana de Oftalmología

ISSN 1561-3070 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 2

<< Back Next >>

Rev Cub Oftal 2018; 31 (2)

Neovascular glaucoma and essential iris atrophy

Sánchez AL, Méndez DAM, Domínguez RM, Rodriguez SB, Miqueli RM
Full text How to cite this article

Language: Spanish
References: 12
Page: 1-7
PDF size: 400.54 Kb.


Key words:

neovascular glaucoma, iridocorneal endothelial syndrome, glaucoma.

ABSTRACT

Secondary glaucomas are always difficult to manage, no matter what their causes might be. Among them, neovascular glaucomas pose a challenge to ophthalmologists, due to the factors bringing them about and the great visual loss they produce. On the other hand, iridocorneal endothelial syndrome is an uncommon condition. Glaucoma develops in about 50% of the cases, depending on the prevailing syndrome, and is much more severe in essential iris atrophy. A clinical case is presented of a 58-yearold female patient with these two types of secondary glaucoma, one type in each eye.


REFERENCES

  1. Mocanu C, Barascu D, Marinescu F. Neovascular glaucoma-Retrospective study. Ophthalmologica. 2015;49:58-65.

  2. Engelbert M, Del Priore L, Al-Aswad L. Neovascular glaucoma. Contemporary Ophthalmology. 2008;7(5):1-6.

  3. Shaarawy TM. Glaucoma medical diagnosis and therapy. EE.UU.: Saunders Elsevier; 2009;1:409-17.

  4. Hayreh SS. Neovascular glaucoma. Prog Retin Eye Res. 2007;26:470-85.

  5. Chávez Pardo I, González Fernández M, Aguilar Rodríguez M, Cardoso Guillén E. Intravítrea de triamcinolona en pacientes con rubeosis del iris: presentación de un caso. AMC. 2012 [citado 18 de agosto de 2017];16(6):[aprox. 7 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S102502552012000600010&ln g=es&nrm=iso

  6. Torriente Torriente V, Ruiz Roja B, Vega Torres M, Gamboa Escanelle B, Triana Casado I, Martínez Legón ZC. Facoemulsificación en el síndrome iridocorneoendotelial. Rev Cubana Oftalmol. 2013 [citado 12 de mayo de 2017];26(3). Disponible en: http://www.revoftalmologia.sld.cu/index.php/oftalmologia/article/view/113/html

  7. Azari AA, Rezaei Kanavi M. Iridocorneal endothelial syndrome. J Am Ophthalmol. 2014;132(1):56.

  8. Berbes Villalón E, González Delgado RI. Síndrome iridocorneal. Reporte de un caso. Rev Med Electrón. 2011;33(4):523-7.

  9. Capote A, Cárdenas T, Cruz D, Hernández I. Queratoplastia endotelial con pelado de la descemet asistida con láser de excímero en el síndrome iridocorneoendotelial. Arch Soc Esp Oftalmol. 2013 [citado 12 de mayo de 2017];88(8). Disponible en: http://dialnet.unirioja.es/servlet/articulo?codigo=4368796

  10. American Academy of Ophthalmology. External disease and cornea. EE.UU.: AAO (Basic and Clinical Science Course); 2010. p. 344-5.

  11. Navarro Vivó J, Herrera Hernández N. Síndrome iridocorneoendotelial: presentación de un caso. Rev Med Electrón. 2012;34(5):579-84.

  12. American Academy of Ophtalmology. Glaucoma. EE.UU.: AAO; 2014. p. 142-4.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cub Oftal. 2018;31